Hepatobiliary and Pancreatic Cancer Group
Description
ATLAS Hepatobiliary & Pancreatic Cancer Group (HBPG) is a collaborative network dedicated to addressing Asia-specific unmet needs in hepatobiliary and pancreatic cancers, where a major share of the global disease burden resides. Established in September 2025, HBPG is building a practical pathway from real-world evidence to interventional studies by convening investigators across the region and engaging a broad range of partners, including industry. We are developing a retrospective master-protocol framework to describe treatment patterns and outcomes across hepatobiliary, pancreatic, and related tumors. In parallel, HBPG collaborates with international partners on patient-reported outcome tools. Through transparent governance and quality management, HBPG aims to accelerate feasible, high-quality internatinal studies and translate them into implementable evidence for the region.
Members
|
|
|
|
Chair |
Secretary |
